Nu Holdings Shares Slide on Credit Concerns Despite Record Revenue
Markets Daniel Marsh

Nu Holdings Shares Slide on Credit Concerns Despite Record Revenue

Nu Holdings shares dropped 5.7% Friday after Q1 results showed credit-loss allowances surging 33% and early delinquencies rising, overshadowing record $5 billion revenue.

NU
Ondas Stock Retreats After Record Quarter, Backlog Surges
Earnings James Calloway

Ondas Stock Retreats After Record Quarter, Backlog Surges

Ondas shares slid 5.26% to $10.62 Friday after a 26.52% jump, as Q1 revenue hit $50.1 million and backlog swelled to $457 million.

ONDS
Bank of America Settles Double-Fee ATM Claims for $2.25M
Regulation James Calloway

Bank of America Settles Double-Fee ATM Claims for $2.25M

Bank of America will pay $2.25 million to settle claims it charged customers double out-of-network balance-inquiry fees at 7-Eleven ATMs. Claim deadline is June 29.

BAC
Singapore Airlines Profit Plunges 57% on Air India Losses and Rising Fuel Costs
Earnings James Calloway

Singapore Airlines Profit Plunges 57% on Air India Losses and Rising Fuel Costs

Singapore Airlines' net profit fell 57.4% to S$1.18 billion, weighed down by Air India losses and higher fuel costs. The airline warns of further margin pressure in the coming year.

EWS
AI Chip Giant Nvidia Faces Pivotal Earnings Test This Week
Earnings James Calloway

AI Chip Giant Nvidia Faces Pivotal Earnings Test This Week

Nvidia shares slipped 4.4% on Friday, though the stock still posted a 4.7% weekly gain. Investors now await the company's quarterly results on Wednesday, which will serve as a major test for the AI-led market surge.

NVDA AMD INTC AAPL MSFT GOOGL AMZN META TSLA
Anthropic's $900B Valuation Pressures OpenAI's IPO Ambitions
IPO Michael Okonkwo

Anthropic's $900B Valuation Pressures OpenAI's IPO Ambitions

Anthropic's $900 billion valuation tops OpenAI's $852 billion, challenging its IPO push. SoftBank gains $45 billion from OpenAI stake.

MSFT AMZN GOOGL TSLA
AI IPO Momentum Puts Spotlight on Databricks' $134B Valuation
IPO Michael Okonkwo

AI IPO Momentum Puts Spotlight on Databricks' $134B Valuation

Databricks, valued at $134 billion privately, draws focus as AI IPOs heat up. The company raised $7 billion and reported a $5.4B annualized revenue run-rate.

SNOW CRS
Stripe Private Valuation Hits $175.6B, IPO Still on Hold
IPO Michael Okonkwo

Stripe Private Valuation Hits $175.6B, IPO Still on Hold

Forge values Stripe at $175.62 billion, up from $159 billion in February. The fintech remains private with no IPO timeline, as public market peers lag.

PYPL SQ
Anthropic Nears $900B Valuation in Record $30B Funding Round
IPO Michael Okonkwo

Anthropic Nears $900B Valuation in Record $30B Funding Round

Anthropic has reportedly agreed to a $30 billion funding round at a $900 billion valuation, nearly tripling its previous valuation and positioning it for a potential IPO.

GOOGL MSFT AMZN NVDA ANET
SpaceX Eyes June Nasdaq Debut with $1.75 Trillion Valuation, BlackRock in Talks
IPO Michael Okonkwo

SpaceX Eyes June Nasdaq Debut with $1.75 Trillion Valuation, BlackRock in Talks

SpaceX is moving toward a potential June IPO on Nasdaq, targeting a $1.75 trillion valuation. Shareholders approved a 5-for-1 stock split, and BlackRock is in talks for a major investment.

TSLA MSFT AMZN GOOGL AAPL NVDA BLK
Hanmi Financial Stock Declines as Dividend Date Approaches and Regional Banks Retreat
Markets Daniel Marsh

Hanmi Financial Stock Declines as Dividend Date Approaches and Regional Banks Retreat

Hanmi Financial shares declined 4.2% last week, more than the broader regional bank index, as rising bond yields and inflation worries pressured the sector. The company's $0.28 dividend is set for payment on May 20.

HAFC HOPE PCB RBB
MeiraGTx Stock Dips 5.5% After Weekly Slide; FDA Designation and Funding in Focus
Markets Daniel Marsh

MeiraGTx Stock Dips 5.5% After Weekly Slide; FDA Designation and Funding in Focus

MeiraGTx shares fell 5.5% Friday to $9.40, ending a 4.3% weekly drop, as the company reported a Q1 net loss of $46.3 million and advanced regulatory filings for key gene therapies.

MGTX LLY JNJ